Mainguet P, Fiasse R, Turine J B
Digestion. 1977;16(1-2):69-76. doi: 10.1159/000198057.
42 outpatients with chronic diarrhoea of varying origin received individually adapted doses (2--12 mg) of loperamide for a median time of 543 days (range 140--1,159 days). In most cases, the mean daily stool frequency dropped significantly and stool consistency improved clearly; the beneficial effects of the drug were maintained over the entire treatment period. Also, patients with diarrhoea of organic origin tended to react more favourably to loperamide than patients with functional diarrhoea. No drug-related changes in laboratory parameters could be detected and clinical side effects were virtually nil. No morphine-like effect of loperamide could be evidence by means of the pupil diameter changes after naloxone administration.
42例病因各异的慢性腹泻门诊患者接受了个体化调整剂量(2 - 12毫克)的洛哌丁胺治疗,中位治疗时间为543天(范围140 - 1159天)。在大多数情况下,平均每日排便次数显著下降,粪便稠度明显改善;药物的有益效果在整个治疗期间得以维持。此外,器质性腹泻患者对洛哌丁胺的反应往往比对功能性腹泻患者更有利。未检测到与药物相关的实验室参数变化,临床副作用几乎为零。给予纳洛酮后,未通过瞳孔直径变化证明洛哌丁胺有吗啡样效应。